Todd Anderman
Chief Legal Officer · OCULAR THERAPEUTIX, INC
IndividualSelling only2 10b5-1 trades
- 2024
- Oct 13, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Todd Anderman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Pravin Dugel - $1.94M in OCUL purchases and sales in the last 12 months
- Richard L. Md Lindstrom - $461K in OCUL purchases and sales in the last 12 months
- Namrata Saroj - $278K in OCUL purchases and sales in the last 12 months
- Nadia Waheed - $221K in OCUL purchases and sales in the last 12 months
- Donald Notman - $216K in OCUL purchases and sales in the last 12 months
- Jeffrey S. Heier - $204K in OCUL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Todd Anderman?
Todd Anderman is a corporate insider, tracked as Chief Legal Officer of OCULAR THERAPEUTIX, INC (OCUL). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Todd Anderman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Todd Anderman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($225K) across all tracked filings.
